United States Neutropenia Drugs Market Report 2017

January 2017 | 120 pages | ID: U85BF031E0DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Neutropenia Drugs

Revenue, means the sales value of Neutropenia Drugs

This report studies sales (consumption) of Neutropenia Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Apotex Inc.
• Biogenomics Limited
• Cellerant Therapeutics, Inc.
• Coherus BioSciences, Inc.
• Dr. Reddy’s Laboratories Limited
• Ligand Pharmaceuticals, Inc.
• NAL Pharmaceuticals Ltd.
• Prolong Pharmaceuticals, LLC
• Richter Gedeon Nyrt.
• Sandoz International GmbH

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Capsule
• Injection

Split by applications, this report focuses on sales, market share and growth rate of Neutropenia Drugs in each application, can be divided into

• Hospital
• Clinic

Contents

United States Neutropenia Drugs Market Report 2017

1 NEUTROPENIA DRUGS OVERVIEW

1.1 Product Overview and Scope of Neutropenia Drugs
1.2 Classification of Neutropenia Drugs
  1.2.1 Capsule
  1.2.2 Injection
1.3 Application of Neutropenia Drugs
  1.3.1 Hospital
  1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Neutropenia Drugs (2011-2021)
  1.4.1 United States Neutropenia Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Neutropenia Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES NEUTROPENIA DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Neutropenia Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Neutropenia Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Neutropenia Drugs Average Price by Manufactures (2015 and 2016)
2.4 Neutropenia Drugs Market Competitive Situation and Trends
  2.4.1 Neutropenia Drugs Market Concentration Rate
  2.4.2 Neutropenia Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NEUTROPENIA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Neutropenia Drugs Sales and Market Share by States (2011-2016)
3.2 United States Neutropenia Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Neutropenia Drugs Price by States (2011-2016)

4 UNITED STATES NEUTROPENIA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Neutropenia Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Neutropenia Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Neutropenia Drugs Price by Type (2011-2016)
4.4 United States Neutropenia Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES NEUTROPENIA DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Neutropenia Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Neutropenia Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEUTROPENIA DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Apotex Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neutropenia Drugs Product Type, Application and Specification
    6.1.2.1 Capsule
    6.1.2.2 Injection
  6.1.3 Apotex Inc. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Biogenomics Limited
  6.2.2 Neutropenia Drugs Product Type, Application and Specification
    6.2.2.1 Capsule
    6.2.2.2 Injection
  6.2.3 Biogenomics Limited Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Cellerant Therapeutics, Inc.
  6.3.2 Neutropenia Drugs Product Type, Application and Specification
    6.3.2.1 Capsule
    6.3.2.2 Injection
  6.3.3 Cellerant Therapeutics, Inc. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Coherus BioSciences, Inc.
  6.4.2 Neutropenia Drugs Product Type, Application and Specification
    6.4.2.1 Capsule
    6.4.2.2 Injection
  6.4.3 Coherus BioSciences, Inc. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Dr. Reddy’s Laboratories Limited
  6.5.2 Neutropenia Drugs Product Type, Application and Specification
    6.5.2.1 Capsule
    6.5.2.2 Injection
  6.5.3 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Ligand Pharmaceuticals, Inc.
  6.6.2 Neutropenia Drugs Product Type, Application and Specification
    6.6.2.1 Capsule
    6.6.2.2 Injection
  6.6.3 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 NAL Pharmaceuticals Ltd.
  6.7.2 Neutropenia Drugs Product Type, Application and Specification
    6.7.2.1 Capsule
    6.7.2.2 Injection
  6.7.3 NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Prolong Pharmaceuticals, LLC
  6.8.2 Neutropenia Drugs Product Type, Application and Specification
    6.8.2.1 Capsule
    6.8.2.2 Injection
  6.8.3 Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Richter Gedeon Nyrt.
  6.9.2 Neutropenia Drugs Product Type, Application and Specification
    6.9.2.1 Capsule
    6.9.2.2 Injection
  6.9.3 Richter Gedeon Nyrt. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Sandoz International GmbH
  6.10.2 Neutropenia Drugs Product Type, Application and Specification
    6.10.2.1 Capsule
    6.10.2.2 Injection
  6.10.3 Sandoz International GmbH Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview

7 NEUTROPENIA DRUGS MANUFACTURING COST ANALYSIS

7.1 Neutropenia Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neutropenia Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neutropenia Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neutropenia Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEUTROPENIA DRUGS MARKET FORECAST (2016-2021)

11.1 United States Neutropenia Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Neutropenia Drugs Sales Forecast by Type (2016-2021)
11.3 United States Neutropenia Drugs Sales Forecast by Application (2016-2021)
11.4 Neutropenia Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neutropenia Drugs
Table Classification of Neutropenia Drugs
Figure United States Sales Market Share of Neutropenia Drugs by Type in 2015
Figure Capsule Picture
Figure Injection Picture
Table Application of Neutropenia Drugs
Figure United States Sales Market Share of Neutropenia Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Neutropenia Drugs Sales and Growth Rate (2011-2021)
Figure United States Neutropenia Drugs Revenue and Growth Rate (2011-2021)
Table United States Neutropenia Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Neutropenia Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Neutropenia Drugs Sales Share by Manufacturers
Figure 2016 Neutropenia Drugs Sales Share by Manufacturers
Table United States Neutropenia Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Neutropenia Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Neutropenia Drugs Revenue Share by Manufacturers
Table 2016 United States Neutropenia Drugs Revenue Share by Manufacturers
Table United States Market Neutropenia Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Neutropenia Drugs Average Price of Key Manufacturers in 2015
Figure Neutropenia Drugs Market Share of Top 3 Manufacturers
Figure Neutropenia Drugs Market Share of Top 5 Manufacturers
Table United States Neutropenia Drugs Sales by States (2011-2016)
Table United States Neutropenia Drugs Sales Share by States (2011-2016)
Figure United States Neutropenia Drugs Sales Market Share by States in 2015
Table United States Neutropenia Drugs Revenue and Market Share by States (2011-2016)
Table United States Neutropenia Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Neutropenia Drugs by States (2011-2016)
Table United States Neutropenia Drugs Price by States (2011-2016)
Table United States Neutropenia Drugs Sales by Type (2011-2016)
Table United States Neutropenia Drugs Sales Share by Type (2011-2016)
Figure United States Neutropenia Drugs Sales Market Share by Type in 2015
Table United States Neutropenia Drugs Revenue and Market Share by Type (2011-2016)
Table United States Neutropenia Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neutropenia Drugs by Type (2011-2016)
Table United States Neutropenia Drugs Price by Type (2011-2016)
Figure United States Neutropenia Drugs Sales Growth Rate by Type (2011-2016)
Table United States Neutropenia Drugs Sales by Application (2011-2016)
Table United States Neutropenia Drugs Sales Market Share by Application (2011-2016)
Figure United States Neutropenia Drugs Sales Market Share by Application in 2015
Table United States Neutropenia Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Neutropenia Drugs Sales Growth Rate by Application (2011-2016)
Table Apotex Inc. Basic Information List
Table Apotex Inc. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Apotex Inc. Neutropenia Drugs Sales Market Share (2011-2016)
Table Biogenomics Limited Basic Information List
Table Biogenomics Limited Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenomics Limited Neutropenia Drugs Sales Market Share (2011-2016)
Table Cellerant Therapeutics, Inc. Basic Information List
Table Cellerant Therapeutics, Inc. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cellerant Therapeutics, Inc. Neutropenia Drugs Sales Market Share (2011-2016)
Table Coherus BioSciences, Inc. Basic Information List
Table Coherus BioSciences, Inc. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Coherus BioSciences, Inc. Neutropenia Drugs Sales Market Share (2011-2016)
Table Dr. Reddy’s Laboratories Limited Basic Information List
Table Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales Market Share (2011-2016)
Table Ligand Pharmaceuticals, Inc. Basic Information List
Table Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales Market Share (2011-2016)
Table NAL Pharmaceuticals Ltd. Basic Information List
Table NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales Market Share (2011-2016)
Table Prolong Pharmaceuticals, LLC Basic Information List
Table Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales Market Share (2011-2016)
Table Richter Gedeon Nyrt. Basic Information List
Table Richter Gedeon Nyrt. Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Richter Gedeon Nyrt. Neutropenia Drugs Sales Market Share (2011-2016)
Table Sandoz International GmbH Basic Information List
Table Sandoz International GmbH Neutropenia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz International GmbH Neutropenia Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neutropenia Drugs
Figure Manufacturing Process Analysis of Neutropenia Drugs
Figure Neutropenia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Neutropenia Drugs Major Manufacturers in 2015
Table Major Buyers of Neutropenia Drugs
Table Distributors/Traders List
Figure United States Neutropenia Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Neutropenia Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Neutropenia Drugs Production Forecast by Type (2016-2021)
Table United States Neutropenia Drugs Consumption Forecast by Application (2016-2021)
Table United States Neutropenia Drugs Sales Forecast by States (2016-2021)
Table United States Neutropenia Drugs Sales Share Forecast by States (2016-2021)